Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal remimazolam versus intranasal esketamine for pediatric preoperative sedation
ChiCTR2500097537Phase 4Not yet recruiting
- Sponsor
- Fuyang People's Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and esketamine in preoperative anxiety and separation anxiety disorder (SAD) (3 arms), sponsored by Fuyang People's Hospital. Primary endpoint: Modified Yale Preoperative Anxiety Scale score. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
remimazolamesketamine
03
Conditions
preoperative anxietyseparation anxiety disorder (SAD)
Beyond the preview
Go deeper on ChiCTR2500097537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097537.